Essential learning tools for continuing medical education are a challenge in today's rapidly evolving field of reproductive medicine. The Midwest Reproductive Symposium International (MRSi) is a yearly conference held in Chicago, IL. The conference is targeted toward physicians, geneticists, nurses, allied health professionals, mental health professionals, business administration professionals, and reproductive endocrinology and infertility (REI) fellows engaged in the practice of reproductive medicine. In addition to the scientific conference agenda, there are specific sessions for nurses, mental health professionals, and REI fellows. Unique to the MRSi conference, there is also a separate BBusiness Minds^session to provide education on business acumen as it is an important element to running a department, division, or private clinic.
Essential learning tools for continuing medical education are a challenge in today's rapidly evolving field of reproductive medicine. The Midwest Reproductive Symposium International (MRSi) is a yearly conference held in Chicago, IL. The conference targets physicians, geneticists, nurses, allied health professionals, mental health professionals, business administration professionals, and reproductive endocrinology and infertility (REI) fellows engaged in the practice of reproductive medicine. In addition to the scientific conference agenda, there are specific sessions for nurses, mental health professionals, and REI fellows. Unique to the MRSi conference, there is also a separate BBusiness Minds^session to provide education on business acumen as it is a relevant element to running a department, division, or private clinic.
Reproductive medicine is a complicated field fraught with exceedingly complex pharmacologic protocols. The research surrounding which medications are effective, how they interact to achieve ideal reproductive environments, and how they affect patients physically and psychologically is continually evolving. Clinicians are responsible for staying well informed of any advances that may improve the patient experience as well as their likelihood of achieving pregnancy and live delivery. Without specific guidelines in these areas, practitioners need an education that is practical and delivered by experts with a broad knowledge base and experience. Several of the experts presenting at MRSi also contribute to ASRM practice guidelines/committee opinions, and while guidelines may lag behind conference presentations on new topics, these new topics are essential to understand.
Every year, core topics are chosen to represent innovative technology or new advances in the field. The core topics of the meeting include the pharmacology of reproductive medicine to establish patient-specific ovarian stimulation protocols, understanding the ovary and declining or impaired fertility as well as ovarian hyperstimulation syndrome (OHSS), and techniques to identify the optimal embryo for transfer. Expert speakers from around the world will address the core topics and specifically discuss preimplantation genetic testing for aneuploidy (PGT-A), chromosomal mosaicism, optimizing implantation in frozen embryo transfer cycles, utilizing the uterine receptivity assay, and advances in oocyte vitrification. The general scientific sessions at the conference will focus on these core topics and geared toward all fertility healthcare providers.
While PGT-A was first performed over 28 years ago, the science and role of PGT-A testing is evolving with new scientific advances and new technologies, making continued education even more important [1, 2] . As PGT-A technology transitioned from methods such as fluorescence in situ hybridization (FISH), quantitative polymerase chain reaction (qPCR), microarrays (single nucleotide polymorphism (SNPs), and comparative genomic hybridization (aCGH)) and toward more sensitive, with higher resolution, nextgeneration sequencing methods [3] , clinicians and healthcare providers receive complex reports that can be difficult to understand. Mosaicism is now frequently reported out by some laboratories. Mosaic results have resulted in many questions regarding criteria for transfer and future obstetric follow-up for these patients [4] . Some studies suggest that while the pregnancy rates with mosaic embryos are lower than with a euploid embryos, there are still successful implantations and normal deliveries from mosaic embryo transfers [5, 6] . Dr. Nathan Treff will discuss the laboratory perspective regarding mosaicism and its utility in determining whether an embryo could be considered for uterine transfer. Drs. David Adamson, Nathan Treff, and William G. Kearns will conduct a workshop on clinical decisions involved in the transfer of mosaic embryos. Determining the legal and psychological ramifications of transferring these embryos remains to be determined, and Dr. Richard Scott and Dr. Rick Paulson will debate the benefits and concerns of PGT-A on trophectoderm cells.
When an embryo fails to implant, the question often arises whether it was due to the embryo or the endometrium. In the case that a PGT-A euploid embryo is transferred, attention is often turned to the endometrium. The fact that more than 40% of high-grade euploid embryos fail to implant, along with cases of recurrent unexplained implantation failure or miscarriage, suggest that endometrial receptivity plays a critical role in assisted reproductive technology outcomes [7] . There are currently different methods to assess endometrial receptivity via either the RNA-seq approach examining >238 genes or the original custom DNA microarray chip examining 238 genes [7] . Both tests are limited because the biopsy and evaluation are typically performed the cycle before embryo transfer, and many endometrial and systemic factors may not be consistent between cycles thus shifting the window of implantation [8] . Dr. Angeline Beltsos will further delve into the issues surrounding luteal phase testing for uterine receptivity using either the ERA or other technologies. However, only focusing on the timing of the transfer, based on days of progesterone exposure, may not be enough. A test for the actual endometrial defect that may be resulting from endometriosis or other factors has yet to be developed [9] .
There is a nationwide trend toward frozen/thaw embryo transfer (FET) to reduce the risks of ovarian hyperstimulation (OHSS), low birth weight (LBW) (< 2500 g), small for gestational age (SGA), preterm LBW, preterm delivery, placenta previa, and perinatal mortality [10] . There are also concerns regarding large for gestational age and preeclampsia in FET transfers versus fresh transfer. Given the association between elevated progesterone and deleterious effects on the endometrium during the window of implantation, many ART programs are recommending cryopreservation of embryos when progesterone is elevated during the initial fresh IVF cycle [11] . Ways to optimize the frozen embryo transfer success rates while also considering patient age, diagnosis, history, and center-specific success rates will be further explained by Dr. Bruce Shapiro.
Due to the improved societal education around reduced oocyte reserve and quality with advancing reproductive age, oocyte vitrification is increasing in popularity with both social egg freezing and oncofertility arenas [12] . While oocyte vitrification has grown in success and popularity, the lack of oocyte rejuvenation is a limitation in the field. Dr. Peter Nagy will address new technologies and recommendations regarding oocyte vitrification as well as introduce ways to energize weak eggs or possibly use egg precursor cells to improve ovarian function.
In addition to the general scientific sessions, there is a separate curriculum dedicated to the education of mental health professionals. Given the anxiety and depression scores of women with infertility are similar to those associated with other severe medical conditions like cancer, mental health is clearly an integral part of the patient journey through fertility care [13] . Intentional teaching of methods to handle these discussions and educating care providers must be reviewed on a regular basis. This year, there will be key lectures on trans-parenting, recurrent pregnancy loss, and ways to cope with the end of treatment. In an era of social networking and access to communication from a variety of parties, many patients often find themselves seeking counsel from online forums. Drs. Jones, Rouff, and Silverman will debate the pros and cons of online forums and give ways to support patients who may be using these methods for medical advice and comfort. As previously discussed, the therapeutic implications of PGT-A will be debated in the scientific session, and Dr. Lawson will address the equally critical emotional pitfalls with PGT-A.
Two additional special practicum sessions are available for both nurses and REI fellows. The nursing sessions focus on building bridges between the administrative and clinical teams as well as nursing tips for supporting patients with endometriosis, male factor infertility, transgender patients, and third-party reproduction. The REI fellow sessions are structured to guide the fellows in making the transition from trainee to attending. Dr. Marcelle Cedars will give a lecture on the importance of mentorship and use of a mentor throughout a medical career to grow as a clinician and researcher. A panel of physicians will be available to answer questions regarding academic, group, and solo private practice, to help guide the fellows to make the best decision. Regardless of the practice venue chosen, all new physicians will need to market themselves to inform surrounding physicians of their new practice, and Lisa Duran and Adrian Elorza will provide essential marketing suggestions.
The field of reproductive medicine is complicated in a way that is unique to healthcare and requires a team of healthcare professionals with a variety of training and backgrounds. Often the source of patients infertility is multifaceted and requires that each treatment be individualized to the patients' needs. This creates a significant challenge for physicians who must assimilate a substantial quantity of complex information in a rapidly changing field of medicine. Attending conferences that present and discuss these ideas is essential for practitioners, so they can ensure they are practicing up-todate, evidence-based medicine. Given the intimate environment of the MRSi conference and its focus on interactive presentations, there are ample opportunities for attendees to ask questions and gain insight from leaders in the field.
In addition to the speakers already noted, the following speakers will be present at the MRSi 2018: Paul Brezina
